相关实验视频

Updated: Sep 12, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

376

在1型糖尿病患者中,与健康对照人群相比,乙盐酸和vorapaxar的活性较低,而4-methylcatechol的活性更高

Markéta Paclíková1, Lukáš Konečný2, Alejandro Carazo2

  • 1Department of Internal Medicine-Metabolic Care and Gerontology, Faculty of Medicine in Hradec Králové, University Hospital, Charles University, Hradec Králové, Czech Republic.

Cardiovascular diabetology
|August 7, 2025
PubMed
概括

糖尿病患者对阿司匹林等常见的抗血小板药物表现出耐药性. 然而,实验性化合物4-甲基甲基醇在1型糖尿病患者中显示出强大的抗血小板作用.

关键词:
4 - 甲基甲基醇 (甲基甲基甲基醇)聚合是一种聚合.糖尿病是一种糖尿病.血小板是血小板的组成部分.

更多相关视频

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

295
Fixation and Operational Method for Abdominal Massage in T2DM Mice05:57

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

331

相关概念视频

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
260
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
262